JP2021504327A5 - - Google Patents

Download PDF

Info

Publication number
JP2021504327A5
JP2021504327A5 JP2020528044A JP2020528044A JP2021504327A5 JP 2021504327 A5 JP2021504327 A5 JP 2021504327A5 JP 2020528044 A JP2020528044 A JP 2020528044A JP 2020528044 A JP2020528044 A JP 2020528044A JP 2021504327 A5 JP2021504327 A5 JP 2021504327A5
Authority
JP
Japan
Prior art keywords
microcapsules
solid preparation
particle
multiparticulate
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020528044A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021504327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/082156 external-priority patent/WO2019101832A1/en
Publication of JP2021504327A publication Critical patent/JP2021504327A/ja
Publication of JP2021504327A5 publication Critical patent/JP2021504327A5/ja
Pending legal-status Critical Current

Links

JP2020528044A 2017-11-27 2018-11-22 凍結乾燥多粒子固形製剤 Pending JP2021504327A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17203799.6 2017-11-27
EP17203799 2017-11-27
PCT/EP2018/082156 WO2019101832A1 (en) 2017-11-27 2018-11-22 Freeze-dried multiparticulate solid dosage form

Publications (2)

Publication Number Publication Date
JP2021504327A JP2021504327A (ja) 2021-02-15
JP2021504327A5 true JP2021504327A5 (https=) 2021-08-19

Family

ID=60473407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020528044A Pending JP2021504327A (ja) 2017-11-27 2018-11-22 凍結乾燥多粒子固形製剤

Country Status (6)

Country Link
US (1) US20210015753A1 (https=)
EP (1) EP3716953A1 (https=)
JP (1) JP2021504327A (https=)
KR (1) KR20200093608A (https=)
CN (1) CN111432804A (https=)
WO (1) WO2019101832A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118160802A (zh) * 2024-04-01 2024-06-11 青岛安信制果食品有限公司 一种冻干食品及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0609265B1 (en) * 1991-10-11 1997-05-28 Abbott Laboratories Unit-of-use reagent composition for specific binding assays
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
MXPA05009079A (es) * 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
US20080031949A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. High dose orally dissolvable/disintegrable lyophilized dosage form
KR20100047869A (ko) 2007-07-19 2010-05-10 디에스엠 아이피 어셋츠 비.브이. 친유성 헬스 성분의 정제화가능한 배합물
PL2057984T3 (pl) 2007-11-09 2010-05-31 Acino Pharma Ag Tabletki z hydromorfonem o przedłużonym uwalnianiu
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
BE1019142A3 (fr) * 2011-01-21 2012-03-06 Vesale Pharma S A Substance probiotique microencapsulee.
EP2606879A1 (en) 2011-12-21 2013-06-26 Hexal AG Multiple unit pellet tablet formulation comprising an opioid
KR102250588B1 (ko) * 2013-07-02 2021-05-12 오스트리아노바 싱가포르 피티이 리미티드 캡슐화 세포의 동결-건조 방법, 동결 건조된 캡슐화 세포, 동결 건조된 캡슐화 세포를 함유하는 조성물, 및 상기 세포 및 조성물의 용도
ES2863048T3 (es) * 2014-05-05 2021-10-08 Basf Se Formulación de vitamina liposoluble
ES3005432T3 (en) * 2014-08-05 2025-03-14 Advanced Bionutrition Corp Composition comprising hydrophobic biologically active compounds and method for preparing said composition
US20180235899A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method

Similar Documents

Publication Publication Date Title
Eratte et al. Recent advances in the microencapsulation of omega-3 oil and probiotic bacteria through complex coacervation: A review
Zhou et al. Evaluation of the physicochemical stability and digestibility of microencapsulated esterified astaxanthins using in vitro and in vivo models
JP5339920B2 (ja) 乳剤
KR100811284B1 (ko) 마이크로캡슐의 캡슐화된 응집체 및 그의 제조 방법
JP6214395B2 (ja) マイクロカプセル化されたプロバイオティクス細菌を含む安定なソフトゲルカプセルを製造する方法
ES2610968T3 (es) Composiciones y métodos para incrementar la estabilidad de aditivos para productos alimentarios
CN105533691A (zh) 一种新型微纳米级鱼油/藻油微胶囊及其制备工艺
EP2825057B1 (en) Oxidixable fatty acid composition delivery form
JP2012505190A (ja) 咀嚼可能なゲル化エマルジョン
GB2223943A (en) Oral disage forms of omega-3 polyunsaturated acids
JP2005522313A5 (https=)
JP2018115185A (ja) 医薬組成物
JP2020090508A5 (https=)
JP2005527207A (ja) 生理的に認容される、リン脂質を含有する、安定でかつ硬質のマトリックス
JP2021504327A5 (https=)
Anbudhasan et al. Development of omega 3 fatty acid enriched stable functional foods: Challenges and options
Vijaykrishnaraj et al. Polyunsaturated fatty acid fortification
Singh et al. Recent advances in the novel formulation of docosahexaenoic acid for effective delivery, associated challenges and its clinical importance
JP2006137759A (ja) 生理学的に活性な脂肪酸の使用
JP2024534997A (ja) 脂肪又は油の小滴を含む組成物及びその生成方法
JP2021519798A5 (https=)
JPWO2019197432A5 (https=)
JP2021504327A (ja) 凍結乾燥多粒子固形製剤
US12514826B2 (en) Delivery system for polyunsaturated fatty acids
JP4473380B2 (ja) 乾燥マイクロカプセルの製造方法